High-Potency Cannabis Use Associated With Higher Risk for Psychosis
Researchers investigated whether high-potency cannabis may be associated with a higher risk of psychosis and cannabis use disorder compared with lower-potency products.
Researchers investigated whether high-potency cannabis may be associated with a higher risk of psychosis and cannabis use disorder compared with lower-potency products.
Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.
With medical and recreational use cannabis becoming more readily available throughout the United States, mental health clinicians need to know the evidence that’s been discovered in order to counsel patients. Researchers in this review examined evidence from controlled trials in order to outline the therapeutic use of cannabinoids for various medical conditions and any possible side effects.
Researchers examined the extent cannabis use is associated with magnetic resonance imaging–measured cerebral cortical thickness development during adolescence.